Zusammenfassung
Durch Alkoholkonsum bedingte Veränderungen von Kognition, Verhalten und sozialer Interaktion zählen zu den häufigsten psychiatrischen Erkrankungen. Unter alkoholbedingten Störungen fasst man insbesondere Alkoholintoxikation, schädlichen Gebrauch, Alkoholabhängigkeit und assoziierte Syndrome wie Alkoholentzug, psychotische Störung, amnestisches Syndrom und andere psychische Störungen oder Verhaltensstörungen zusammen. Diese sowie auch internistische und neurologische Folgeerkrankungen des Alkoholkonsums führen dazu, dass Störungen durch Alkohol ein erhebliches medizinisches und soziales Problem darstellen. In Bezug auf die Ätiopathogenese der Alkoholerkrankung werden verschiedene soziale und lerntheoretische, aber auch genetische und biologische Theorien diskutiert. Entsprechend kommen in der Therapie unterschiedliche Ansätze zum Tragen, z. B. Psychotherapie, sozialpsychiatrische Maßnahmen oder/und Therapie mit Anti-Craving-Substanzen.
Literatur
Adams M, Effertz T (2010) Effective prevention against risky underage drinking – the need for higher excise taxes on alcoholic beverages in germany. Alcohol Alcohol (Oxford, Oxfordshire) 45(4):387–394
Agarwal DP, Goedde HW (1990) Alcohol metabolism, alcohol intolerance and alcoholism. Biochemical and pharmacogenetic approaches. Springer, Berlin/Heidelberg/New York/Tokio
Alldredge BK, Lowenstein DH, Simon RP (1989) Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 87:645–648
Amato L, Minozzi S, Vecchi S, Davoli M (2010) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010(3):CD005063
Ambrose ML, Bowden SC, Whelan G (2001) Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res 25:112–116
Ballenger JC, Post RM (1978) Kindling as a model for alcoholic withdrawal syndromes. Br J Psychiatry 133:1–14
Becker HC (1998) Kindling in alcohol withdrawal. Alcohol Health Res World 22:25–33
Berglund M, Thelander S, Salaspuro M et al (2003) Treatment of alcohol abuse: an evidence-based review. Alcohol Clin Exp Res 27:1645–1656
Berner MM, Kriston L, Bentele M, Harter M (2007) The alcohol use disorders identification test for detecting at-risk drinking: a systematic review and meta-analysis. J Stud Alcohol Drugs 68(3):461–473
Besson JAQ, Crawford JR, Parker DM, Smith FW (1989) Magnetic resonance imaging in Alzheimer’s disease, multi-infarkt-dementia, alcoholic dementia and Korsakoff` psychosis. Acta Psychiatr Scand 80:451–458
Boening JA (2001) Neurobiology of an addiction memory. J Neural Transm 108:755–765
Bottlender M, Soyka M (2005) Outpatient alcoholism treatment. Predictors of outcome after three years. Alcohol Drug Depend 80:83–89
Brathen G, Ben-Menachem E, Brodtkorb E et al (2005) EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol 12:575–581
Brueck G, Mann K (2006) Alkoholismusspezifische Psychotherapie: Manual mit Behandlungsmodulen. Ärzteverlag, Deutscher
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 158:1789–1795
Conde-Martel A, Gonzalez-Reimers E, Santolaria-Fernandez F et al (1992) Pathogenesis of alcoholic myopathy: roles of ethanol and malnutrition. Drug Alcohol Depend 30:101–110
Cotton J (1979) The familial incidence of alcoholism. A review. J Stud Alcohol 40:89–116
Day E, Bentham P, Callaghan R et al (2004) Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004(1):CD004033
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274–5278
Drogen- und Suchtbericht (2015) Drogenbeauftragte der Bundesregierung, Bundesministerium für Gesundheit. Drogen- und Suchtbericht 2015. www.drogenbeauftragte.de
Edwards G (1996) Süchtig: Die nächste Therapiestunde. In: Mann K, Buchkremer G (Hrsg) Sucht-Grundlagen, Diagnostik, Therapie, Gustav. Fischer, Stuttgart, S 231–242
Effertz T, Mann K (2013) The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. Eur Neuropsychopharmacol 23(7):742–748
Egberts EH (1993) Hepatische Enzephalopathie. In: Schüttler R (Hrsg) Organische Psychosyndrome. Tropon-Symposion, Bd VIII. Springer, Berlin/Heidelberg/New York/Tokio, S 183–194
Ehrenreich H, Mangholz A, Schmitt M et al (1997) OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach. Eur Arch Psychiatry Clin Neurosci 247:51–54
Feuerlein W, Küfner H, Soyka M (1998) Alkohol – Missbrauch und Abhängigkeit, 5. Aufl. Thieme, Stuttgart
Gärtner B (2015) Alkohol – Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle für Suchtfragen (Hrsg) Jahrbuch Sucht 2015. Pabst, Lengerich
Geyer D, Beutel M, Funke W et al (2006) Postakutbehandlung. In: Schmidt LG, Falkai P, Gaebel W (Hrsg) Evidenzbasierte Suchtmedizin – Behandlungsleitlinie Substandbezogene Störungen. Deutscher Ärzteverlag, Köln, S 52–89
Goodwin DW, Schulsinger F, Hermansen L et al (1973) Alcohol problems in adoptees raised apart from alcoholic biological parents. Arch Gen Psychiatry 28:238–243
Graham JR, Woodhouse D, Read FH (1971) Massive thiamine dosage in an alcoholic with cerebellar cortical degeneration. Lancet 2:107
Grant BF, Stinson FS, Dawson DA et al (2004a) Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:361–368
Grant BF, Stinson FS, Dawson DA et al (2004b) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:807–816
Grüngreiff K (1996) Zinkmangel und hepatische Enzephalopathie. Med Welt 47:23–27
Hanke M, John U (2003) Tabak- oder alkohol-attributable stationäre Behandlungen. DMW 128:1387–1390
Heinz A, Beck A, Grusser SM, Grace AA, Wrase J (2009) Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14:108–118
Hillbom M, Pieninkeroinen I, Leone M (2003) Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 17:1013–1030
Hoffmann NG, Harrison PA, Belille CA (1983) Alcoholics anonymous after treatment: attendance and abstinence. Int J Addict 18:311–318
Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598
Jernigan TL, Butters N, Ditraglia G et al (1991) Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res 15:418–427
Kaner EF, Dickinson HO, Beyer FR et al (2007) Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007(2):CD004148
Kendler KS, Heath AC, Neale MC et al (1992) A population-based twin study of alcoholism in women. JAMA 268:1877–1882
Kessler RC, Crum RM, Warner LA et al (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54:313–321
Kiefer F (2004) Funktion endogener Opioide im menschlichen Belohnungs- und Verstärkungssystem. Suchtmedizin 6:180–184
Kiefer F, Dinter C (2013) Novel treatment approaches targeted at learning and memory. Curr Top Behav Neurosci 13:671–684
Kiefer F, Mann K (2005) New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence. Eur J Pharmacol 526:163–171
Kiefer F, Mann K (2007) Evidence-based treatment of alcoholism. [Evidenzbasierte Behandlung der Alkoholabhängigkeit]. Nervenarzt 78(11):1321–1329; quiz 1330–1331
Kiefer F, Wiedemann K (2004) Zur differentiellen Indikationsstellung von Anti-Craving-Substanzen bei Alkoholabhängigkeit. Nervenheilkunde 23:521–526
Kiefer F, Schuckit M, Rietschel M (2010) Genetik der Alkoholabhängigkeit. In: Singer MV, Batra A, Mann K (Hrsg) Alkohol und Tabak. Thieme, Stuttgart
Kiefer F, Witt S, Frank J et al (2011) Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk, and treatment response to acamprosate. Pharmacogenom 11:368–374
Kiefer F, Fauth-Buhler M, Heinz A, Mann K (2013) Neurobiology of behavioral addictions. Neurobiologische Grundlagen der Verhaltenssuchte. Nervenarzt 84:557–562
Konnopka A, König H (2007) Direct and indirect costs, attributable to alcohol consumption in Germany. Pharmacoeconomics 25:605–618
Krampe H, Stawicki S, Wagner T et al (2006) Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 30:86–95
Kraus L, Østhus S, Amundsen EJ (2015) Changes in mortality due to major alcohol-related diseases in four Nordic countries, France and Germany between 1980 and 2009: a comparative age-period-cohort analysis. Addiction 110:1443–1452
Kretz FJ, Löscher W, Peisdersky B et al (1990) Flumazenil (Anexate): Pharmakodynamik, Pharmakokinetik, Indikationen und Kontraindikationen. Med Klin 85:156–160
Küfner H (2000) Ergebnisse von Kurzinterventionen und Kurztherapien bei Alkoholismus – ein Überblick. Suchtmedizin 4:181–192
Küfner H (2003) Therapieevaluation als Evidenzbasis der Suchttherapie. Psychotherapie im Dialog 2:170–177
Küfner H (2010) Epidemiologie des Substanzkonsums und der Suchterkrankungen in Deutschland. Bundesgesundheitsblatt 4:271–281
Küfner H, Feuerlein W, Huber M (1988) Die stationäre Behandlung von Alkoholabhängigen: Ergebnisse der 4-Jahres Katamnesen, mögliche Konsequenzen für Indikationsstellung und Behandlung. Suchtgefahren 34:157–271
Kurella B, Heitmann A, Dormann S, Meister K (1990a) Schlafpolygraphische Untersuchungen und subjektive Schlafeinschätzungen bei abstinenten Alkoholikern. Z Klin Med 45:1519–1522
Kurella B, Heitmann A, Dormann S, Meister K (1990b) Besonderheiten des Schlafes bei abstinenten Alkoholikern. Vergleich alkohol- und altersbedingter Tiefschlafreduktion. Z EEG EMG 21:157–160
Lampert T, Kuntz B, KiGGS Study Group (2014) Tobacco and alcohol consumption among 11- to 17-year-old adolescents: results of the KiGGS study: First follow-up (KiGGS wave 1). [Tabak- und Alkoholkonsum bei 11- bis 17-jahrigen Jugendlichen : Ergebnisse der KiGGS-Studie – Erste Folgebefragung (KiGGS Welle 1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:830–839
Langlais PJ, Mair RG (1990) Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 10:1664–1674
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2224–2260
Lindenmeyer J (1999) Alkoholabhängigkeit. Fortschritte der Psychotherapie, Bd 6. Hogrefe, Göttingen
Loeber S, Mann K (2006) Entwicklung einer evidenzbasierten Psychotherapie bei Alkoholismus – Eine Übersicht. Nervenarzt 5:558–566
Lundahl B, Burke BL (2009) The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol 65:1232–1245
Mann K, Kiefer F (2008) Alcohol and psychiatric and physical disorders. In: Gelder M, Andreasen NC, López-Ibor J, Geddes JR (Hrsg) New Oxford textbook of psychiatry, 2. Aufl. Oxford University Press, Oxford, S 442–447
Mann K, Gunther A, Stetter F, Ackermann K (1999) Rapid recovery from cognitive deficits in abstinent alcoholics: a controlled test-retest study. Alcohol Alcohol 34:567–574
Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:33
Mann K, Schafer DR, Langle G et al (2005) The long-term course of alcoholism, 5, 10 and 16 years after treatment. Addiction 100:797–805
Mann K, Loeber S, Croissant B, Kiefer F (2006) Die qualifizierte Entzugsbehandlung von Alkoholabhängigen: Psychotherapeutische und pharmakologische Strategien. Ärzteverlag, Deutscher
Marlatt GA, Gordon JR (1985) Relapse prevention: maintenance strategies in the treatment of addictive behaviors. Guilford, New York
McGue M (1999) The behavioral genetics of alcoholism. Curr Dir Psychol Sci 8:109–115
Miller NS, Hoffmann NG (1995) Addictions treatment outcomes. Alcohol Treat Q 12:41–55
Miller WR, Rollnick S (1991) Motivational interviewing: preparing people to change addictive behaviour. Guilford, New York
Miller WR, Rollnick S (1999) Motivierende Gesprächsführung. Ein Konzept zur Beratung von Menschen mit Suchtproblemen. Lambertus, Freiburg
Miller WR, Wilbourne PL (2002) Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 97:265–277
Miller WR, Wilbourne PL, Hettema JE (2003) What works? A summary of alcohol treatment outcome research. In: Hester RK, Miller WR (Hrsg) Handbook of alcoholism treatment approaches: effective alternatives, 3. Aufl. Allyn and Bacon, Boston, S 13–63
Minozzi S, Amato L, Vecchi S, Davoli M (2010) Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2010(3):CD005064
Montague PR, Hyman SE, Cohen JD (2004) Computational roles for dopamine in behavioural control. Nature 431:760–767
Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 97:279–292
Mukherjee AB, Ghazanfari A, Svoronos S et al (1987) Transketolase abnormality in cultured fibroblasts from familial chronic alcoholic men and their male offspring. J Clin Invest 79:1039
Mullen KD, Szauter KM, Kaminsky-Russ K (1990) „Endogeneous“ benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81
Müller-Fahrnow W, Ilchmann U, Kühner S et al (2002) Sucht-Rehabilitation in Deutschland: Bestandsaufnahme und Perspektiven. Eine Expertise des Lehrstuhls Versorgungsforschung der Humboldt-Universität zu Berlin, (DVR-Schriften, Bd 32). Verband Deutscher Rentenversicherungsträger, Frankfurt
Naylor CD, O’Rourke K, Detsky AS, Baker JP (1988) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 97:1033–1042
Nixon PF (1984) Is there a genetic component to the pathogenesis of the Wernicke-Korsakoff syndrome? Alcohol Alcohol 19:219–221
Pabst A et al (2013) Substanzkonsum und substanzbezogene Störungen in Deutschland 2012. SUCHT 59(6):321–331
Parsons O, Nixon S (1996) Die neuropsychologische Diagnostik des Alkoholismus: Gegenwärtiger Stand und künftige Perspektiven. In: Mann K, Buchkremer G (Hrsg) Sucht – Grundlagen, Diagnostik, Therapie. Fischer, Stuttgart, S 121–134
Pfeiffer J (1985) Zur Frage atrophisierender Vorgänge im Gehirn chronischer Alkoholiker. Nervenarzt 56:649–657
Plass D, Vos T, Hornberg C, Scheidt-Nave C, Zeeb H, Kramer A (2014) Trends in disease burden in germany: results, implications and limitations of the global burden of disease study. Dtsch Arztebl Int 111(38):629–638
Plauth M, Egberts EH (1993) Was ist gesichert in der Therapie der hepatischen Enzephalopathie. Internist 34:35–42
Poikolainen K (1999) Effectiveness of brief intervention to reduce alcohol intake in primary health care populations: a meta-analysis. Prev Med 28:503–509
Prochaska JO, DiClemente CC (1986) Towards a comprehensive model of change. In: Miller WE, Heather N (Hrsg) Treating addictive behaviors. Process of change. Plenum, New York/London, S 265–273
Regier DA, Farmer ME, Rae DS et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511–2518
Rehm J, Shield KD, Gmel G, Rehm MX, Frick U (2013) Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the european union. Eur Neuropsychopharmacol 23(2):89–97
Rehm J, Anderson P, Barry J, Dimitrov P, Elekes Z, Feijao F et al (2015) Prevalence of and potential influencing factors for alcohol dependence in Europe. Eur Addict Res 21(1):6–18
Reinert DF, Allen JP (2007) The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res 31(2):185–199
Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247–291
Rösner S, Leucht S, Lehert P, Soyka MJ (2008) Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Psychopharmacol 22:11–23
Rubenstein AE, Wainapel SF (1977) Acute hypokalemic myopathy in alcoholism. A clinical entity. Arch Neurol 34:553–555
Rumpf HJ, Kiefer F (2011) DSM-5: Die Aufhebung der Unterscheidung von Abhängigkeit und Missbrauch und die Öffnung für Verhaltenssüchte. Sucht 57(1):45–48
Rumpf HJ, Wohlert T, Freyer-Adam J et al (2013) Screening questionnaires for problem drinking in adolescents: performance of AUDIT, AUDIT-C, CRAFFT and POSIT. Eur Addict Res 19(3):121–127
Satel SL, Kosten TR, Schuckit MA, Fischman MW (1993) Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry 150:695–704
Schmidt LG, Gastpar M, Falkai P, Gaebel W (Hrsg) (2006) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Deutscher Ärzteverlag, Köln
Schuckit MA (2002) Vulnerability factors for alcoholism. In: Davis K (Hrsg) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins Co, Baltimore, S 1399–1411
Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593–1599
Sellers EM, Kalant H (1976) Alcohol intoxication and withdrawal. N Engl J Med 294:757–762
Snyder JL, Bowers TG (2008) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Am J Drug Alcohol Abuse 34:449–461
Soyka M (1995) Die Alkoholkrankheit – Diagnostik und Therapie. Chapman & Hall, Weinheim
Soyka M (1997) Alkoholismus – eine Krankheit und ihre Therapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Soyka M, Schmidt P (2009) Outpatient alcoholism treatment – 24-month outcome and predictors of outcome. Subst Abuse Treat Prev Policy 4:15
Soyka M, Banzer K, Erbas B et al (2006a) Substitutionsbehandlung Drogenabhängiger – rechtliche Grundlagen und neue Ergebnisse der Therapieforschung. Nervenheilkunde 25:286–294
Soyka M, Schmidt F, Schmidt P (2006b) Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence. Pharmacopsychiatry 39:30–34
Spanagel R (2010) A call for systems approaches in addiction research. Addiction 105:791–792
Spanagel R, Kiefer F (2008) Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci 29:109–115
Srisurapanont M, Jarusuraisin N (2005) Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 8:267–280
Staufer K, Andresen H, Vettorazzi E et al (2011) Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology (Baltimore, Md) 54:1640–1649
Steinglass P (1983) Ein lebensgeschichtliches Modell der Alkoholismusfamilie. Familiendynamik 8:69–91
Sterns RH, Riggs JE, Schochet SS (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314:1535–1542
Stinson FS, Grant BF, Dawson DA et al (2005) Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 80:105–116
Sullivan LE, Fiellin DA, O’Connor PG (2005) The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med 118:330–341
Tomko RL, Trull TJ, Wood PK, Sher KJ (2013) Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord 27:1. doi:10.1521/pedi_2013_27_093
Tomko RL, Trull TJ, Wood PK, Sher KJ. (2014). "http://www.ncbi.nlm.nih.gov/pubmed/25248122"Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord. 28(5):734–50
Treutlein J, Cichon S, Ridinger M et al (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66:773–784
Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ (2010) Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord 24:412–426
Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332–340
Uhl GR, Drgon T, Johnson C et al (2008) Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify „connectivity constellation“ and drug target genes with pleiotropic effects. Ann N Y Acad Sci 1141:318–381
Vaillant GE (2003) A 60-year follow-up of alcoholic men. Addiction 98:1043–1051
Victor M (1992) The effects of alcohol on the nervous system. In: Mendelson JH, Mello NK (Hrsg) Medical diagnosis and treatment of alcoholism. Mc Graw-Hill, New York, S 201–262
Vollstadt-Klein S, Loeber S, Kiefer F (2010) Effects of extinction training on mesolimbic cue-reactivity in alcohol dependence. Eur Arch Psychiatry Clin Neurosci 260:51
von der Goltz C, Kiefer F (2009) Learning and memory in the etiopathogenesis of addiction: future implications for therapy? Eur Arch Psychiatry Clin Neurosci 259:183–187
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Kiefer, F., Schuster, R. (2016). Alkoholismus-Forschung, aktuelle Befunde, künftige Perspektiven. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie, Psychosomatik, Psychotherapie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45028-0_61-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-45028-0_61-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-45028-0
eBook Packages: Springer Referenz Medizin